Fig. 2From: Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trialsForrest plots. Forrest plot for the effects of pioglitazone on major adverse cardiac/cardiovascular events (a), a composite of nonfatal myocardial infarction, nonfatal stroke and cardiovascular mortality (b) and myocardial infarction (c)Back to article page